| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.0079 | 0.9 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.9 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |